Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia (Q37602430)
Jump to navigation
Jump to search
scientific article published on 15 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia |
scientific article published on 15 July 2013 |
Statements
1 reference
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia (English)
1 reference
John C Byrd
1 reference
Deborah M Stephens
1 reference
Amy S Ruppert
1 reference
Kami Maddocks
1 reference
Leslie Andritsos
1 reference
Robert Baiocchi
1 reference
Jeffrey Jones
1 reference
Amy J Johnson
1 reference
Lisa L Smith
1 reference
Yuan Zhao
1 reference
Yonghua Ling
1 reference
Junan Li
1 reference
Mitch A Phelps
1 reference
Michael R Grever
1 reference
Joseph M Flynn
1 reference
15 July 2013
1 reference
1 reference
1195-1199
1 reference
Identifiers
1 reference
1 reference
1 reference